NATCO Pharma Limited (NSE: NATCOPHARM; BSE: 524816) has updated that Johnson & Johnson's and Momenta Pharmaceuticals has filed a lawsuit against NATCO and its marketing partner Mylan Pharmaceuticals Inc. (Mylan) & others alleging infringement of two old Patents associated with 20mg/ml and 40mg/ml Glatiramer Acetate Injection. This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner, Mylan believe this is a meritless suit for a product that has been in the market for more than 5 years. Mylan and NATCO will strongly defend against this suit. Shares of Natco Pharma Limited was last trading in BSE at Rs. 687.05 as compared to the previous close of Rs. 704.90. The total number of shares traded during the day was 9442 in over 1733 trades. The stock hit an intraday high of Rs. 703.00 and intraday low of 681.95. The net turnover during the day was Rs. 6518317.00.

Website Created & Maintained by : Chennai Scripts West Mambalam, Chennai - 600 033, Tamil Nadu, India